Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 176Neoplasms 173Carcinoma, Non-Small-Cell Lung 152Prostatic Neoplasms 108Colorectal Neoplasms 105Lung Neoplasms 91Ovarian Neoplasms 82Neoplasm Metastasis 76Multiple Myeloma 72Pancreatic Neoplasms 70Leukemia, Myeloid, Acute 63Endometrial Neoplasms 49Squamous Cell Carcinoma of Head and Neck 47Stomach Neoplasms 45Melanoma 44Lymphoma 44Glioblastoma 42Carcinoma, Renal Cell 42Recurrence 41Brain Neoplasms 41Urinary Bladder Neoplasms 39Carcinoma, Hepatocellular 39Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Sarcoma 37Glioma 36Lymphoma, Non-Hodgkin 35Hematologic Neoplasms 35Leukemia, Lymphocytic, Chronic, B-Cell 34Esophageal Neoplasms 33Small Cell Lung Carcinoma 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × ACTH Syndrome, Ectopic × 30 days × Clear all
NCT03374215 2026-06-05

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

National Institutes of Health Clinical Center (CC)

Recruiting
1,150 enrolled
Endocrine

ACTH Syndrome, Ectopic, Adrenal Gland Neoplasms, Bone Diseases, Metabolic, Cardiovascular Diseases, Hyperaldosteronism, Hyperinsulinism, Hypertension

NCT05804669 2026-06-04

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Crinetics Pharmaceuticals Inc.

Phase 1/2 Recruiting
18 enrolled
Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡